Inventor · disambiguated record
Ssucheng Jeff Hsu
Also filed as: HSU SSUCHENG J · HSU SSUCHENG JEFF
5 granted patents·4 pending applications·32 citations·filing 2007–2021
78Inventor score
Top patents by PatentIndex Score
9 records- 0193US9546368B2Methods for modulating metastasis-associated-in-lung-adenocarcinoma-transcript-1 (MALAT-1) expressionIONIS PHARMACEUTICALS INC·Filed 2012·Granted Jan 17, 2017·16 cites·20 claims
- 0287US10646583B2Antibody drug conjugates (ADC) that bind to CD37 proteinsAGENSYS INC·Filed 2018·Granted May 12, 2020·3 cites·22 claims
- 0384US9925273B2Antibody drug conjugates (ADC) that bind to CD37 proteinsAGENSYS INC·Filed 2014·Granted Mar 27, 2018·8 cites·62 claims
- 0482US8377439B2Antagonist antibodies against EPHB3NOVARTIS AG·Filed 2007·Granted Feb 19, 2013·5 cites·25 claims
- 0565US11633500B2Antibody drug conjugates (ADC) that bind to CD37 proteinsAGENSYS INC·Filed 2020·Granted Apr 25, 2023·0 cites·19 claims
- 0659US2011002934A1Uses of anti-cd40 antibodiesNOVARTIS AG·Filed 2008·Application pending·0 cites
- 0754US2020030330A1Bruton's tyrosine kinase inhibitor combinations and uses thereofPHARMACYCLICS LLC·Filed 2019·Application pending·0 cites
- 0853US2023301979A1Combinations for the treatment of cancerEXELIXIS INC·Filed 2021·Application pending·0 cites
- 0951US2017027941A1Bruton's Tyrosine Kinase Inhibitor Combinations and Uses ThereofPHARMACYCLICS LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ssucheng Jeff Hsu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →